世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Global Lovir Drug Intermediate Market Growth 2025-2031
The global Lovir Drug Intermediate market size is predicted to grow from US$ 777 million in 2025 to US$ 1127 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031. A Lovir dr... もっと見る
英語原文をAIを使って翻訳しています。 
図表リストList of TablesTable 1. Lovir Drug Intermediate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Lovir Drug Intermediate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Acyclovir Table 4. Major Players of Zidovudine Table 5. Major Players of Entecavir Table 6. Major Players of Sofosbuvir Table 7. Major Players of Other Table 8. Global Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 9. Global Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Table 10. Global Lovir Drug Intermediate Revenue by Type (2020-2025) & ($ million) Table 11. Global Lovir Drug Intermediate Revenue Market Share by Type (2020-2025) Table 12. Global Lovir Drug Intermediate Sale Price by Type (2020-2025) & (US$/Ton) Table 13. Global Lovir Drug Intermediate Sale by Application (2020-2025) & (Tons) Table 14. Global Lovir Drug Intermediate Sale Market Share by Application (2020-2025) Table 15. Global Lovir Drug Intermediate Revenue by Application (2020-2025) & ($ million) Table 16. Global Lovir Drug Intermediate Revenue Market Share by Application (2020-2025) Table 17. Global Lovir Drug Intermediate Sale Price by Application (2020-2025) & (US$/Ton) Table 18. Global Lovir Drug Intermediate Sales by Company (2020-2025) & (Tons) Table 19. Global Lovir Drug Intermediate Sales Market Share by Company (2020-2025) Table 20. Global Lovir Drug Intermediate Revenue by Company (2020-2025) & ($ millions) Table 21. Global Lovir Drug Intermediate Revenue Market Share by Company (2020-2025) Table 22. Global Lovir Drug Intermediate Sale Price by Company (2020-2025) & (US$/Ton) Table 23. Key Manufacturers Lovir Drug Intermediate Producing Area Distribution and Sales Area Table 24. Players Lovir Drug Intermediate Products Offered Table 25. Lovir Drug Intermediate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 26. New Products and Potential Entrants Table 27. Market M&A Activity & Strategy Table 28. Global Lovir Drug Intermediate Sales by Geographic Region (2020-2025) & (Tons) Table 29. Global Lovir Drug Intermediate Sales Market Share Geographic Region (2020-2025) Table 30. Global Lovir Drug Intermediate Revenue by Geographic Region (2020-2025) & ($ millions) Table 31. Global Lovir Drug Intermediate Revenue Market Share by Geographic Region (2020-2025) Table 32. Global Lovir Drug Intermediate Sales by Country/Region (2020-2025) & (Tons) Table 33. Global Lovir Drug Intermediate Sales Market Share by Country/Region (2020-2025) Table 34. Global Lovir Drug Intermediate Revenue by Country/Region (2020-2025) & ($ millions) Table 35. Global Lovir Drug Intermediate Revenue Market Share by Country/Region (2020-2025) Table 36. Americas Lovir Drug Intermediate Sales by Country (2020-2025) & (Tons) Table 37. Americas Lovir Drug Intermediate Sales Market Share by Country (2020-2025) Table 38. Americas Lovir Drug Intermediate Revenue by Country (2020-2025) & ($ millions) Table 39. Americas Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 40. Americas Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 41. APAC Lovir Drug Intermediate Sales by Region (2020-2025) & (Tons) Table 42. APAC Lovir Drug Intermediate Sales Market Share by Region (2020-2025) Table 43. APAC Lovir Drug Intermediate Revenue by Region (2020-2025) & ($ millions) Table 44. APAC Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 45. APAC Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 46. Europe Lovir Drug Intermediate Sales by Country (2020-2025) & (Tons) Table 47. Europe Lovir Drug Intermediate Revenue by Country (2020-2025) & ($ millions) Table 48. Europe Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 49. Europe Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 50. Middle East & Africa Lovir Drug Intermediate Sales by Country (2020-2025) & (Tons) Table 51. Middle East & Africa Lovir Drug Intermediate Revenue Market Share by Country (2020-2025) Table 52. Middle East & Africa Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 53. Middle East & Africa Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 54. Key Market Drivers & Growth Opportunities of Lovir Drug Intermediate Table 55. Key Market Challenges & Risks of Lovir Drug Intermediate Table 56. Key Industry Trends of Lovir Drug Intermediate Table 57. Lovir Drug Intermediate Raw Material Table 58. Key Suppliers of Raw Materials Table 59. Lovir Drug Intermediate Distributors List Table 60. Lovir Drug Intermediate Customer List Table 61. Global Lovir Drug Intermediate Sales Forecast by Region (2026-2031) & (Tons) Table 62. Global Lovir Drug Intermediate Revenue Forecast by Region (2026-2031) & ($ millions) Table 63. Americas Lovir Drug Intermediate Sales Forecast by Country (2026-2031) & (Tons) Table 64. Americas Lovir Drug Intermediate Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 65. APAC Lovir Drug Intermediate Sales Forecast by Region (2026-2031) & (Tons) Table 66. APAC Lovir Drug Intermediate Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 67. Europe Lovir Drug Intermediate Sales Forecast by Country (2026-2031) & (Tons) Table 68. Europe Lovir Drug Intermediate Revenue Forecast by Country (2026-2031) & ($ millions) Table 69. Middle East & Africa Lovir Drug Intermediate Sales Forecast by Country (2026-2031) & (Tons) Table 70. Middle East & Africa Lovir Drug Intermediate Revenue Forecast by Country (2026-2031) & ($ millions) Table 71. Global Lovir Drug Intermediate Sales Forecast by Type (2026-2031) & (Tons) Table 72. Global Lovir Drug Intermediate Revenue Forecast by Type (2026-2031) & ($ millions) Table 73. Global Lovir Drug Intermediate Sales Forecast by Application (2026-2031) & (Tons) Table 74. Global Lovir Drug Intermediate Revenue Forecast by Application (2026-2031) & ($ millions) Table 75. Greater Pharma Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 76. Greater Pharma Lovir Drug Intermediate Product Portfolios and Specifications Table 77. Greater Pharma Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 78. Greater Pharma Main Business Table 79. Greater Pharma Latest Developments Table 80. LBS Labs Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 81. LBS Labs Lovir Drug Intermediate Product Portfolios and Specifications Table 82. LBS Labs Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 83. LBS Labs Main Business Table 84. LBS Labs Latest Developments Table 85. GlaxoSmithKline Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 86. GlaxoSmithKline Lovir Drug Intermediate Product Portfolios and Specifications Table 87. GlaxoSmithKline Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 88. GlaxoSmithKline Main Business Table 89. GlaxoSmithKline Latest Developments Table 90. Lex Ano Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 91. Lex Ano Lovir Drug Intermediate Product Portfolios and Specifications Table 92. Lex Ano Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 93. Lex Ano Main Business Table 94. Lex Ano Latest Developments Table 95. Salutas Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 96. Salutas Lovir Drug Intermediate Product Portfolios and Specifications Table 97. Salutas Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 98. Salutas Main Business Table 99. Salutas Latest Developments Table 100. Novartis Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 101. Novartis Lovir Drug Intermediate Product Portfolios and Specifications Table 102. Novartis Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 103. Novartis Main Business Table 104. Novartis Latest Developments Table 105. Teva Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 106. Teva Lovir Drug Intermediate Product Portfolios and Specifications Table 107. Teva Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 108. Teva Main Business Table 109. Teva Latest Developments Table 110. Stada Nordic Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 111. Stada Nordic Lovir Drug Intermediate Product Portfolios and Specifications Table 112. Stada Nordic Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 113. Stada Nordic Main Business Table 114. Stada Nordic Latest Developments Table 115. Cimed Industria de Medicamentos Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 116. Cimed Industria de Medicamentos Lovir Drug Intermediate Product Portfolios and Specifications Table 117. Cimed Industria de Medicamentos Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 118. Cimed Industria de Medicamentos Main Business Table 119. Cimed Industria de Medicamentos Latest Developments Table 120. Reman Drug Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 121. Reman Drug Lovir Drug Intermediate Product Portfolios and Specifications Table 122. Reman Drug Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 123. Reman Drug Main Business Table 124. Reman Drug Latest Developments Table 125. L.E.T.I. Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 126. L.E.T.I. Lovir Drug Intermediate Product Portfolios and Specifications Table 127. L.E.T.I. Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 128. L.E.T.I. Main Business Table 129. L.E.T.I. Latest Developments Table 130. Nichi-Iko Pharmaceutical Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 131. Nichi-Iko Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications Table 132. Nichi-Iko Pharmaceutical Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 133. Nichi-Iko Pharmaceutical Main Business Table 134. Nichi-Iko Pharmaceutical Latest Developments Table 135. Choseido Pharmaceutical Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 136. Choseido Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications Table 137. Choseido Pharmaceutical Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 138. Choseido Pharmaceutical Main Business Table 139. Choseido Pharmaceutical Latest Developments Table 140. Shiono Kemikaru Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 141. Shiono Kemikaru Lovir Drug Intermediate Product Portfolios and Specifications Table 142. Shiono Kemikaru Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 143. Shiono Kemikaru Main Business Table 144. Shiono Kemikaru Latest Developments Table 145. Towa Yakuhin Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 146. Towa Yakuhin Lovir Drug Intermediate Product Portfolios and Specifications Table 147. Towa Yakuhin Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 148. Towa Yakuhin Main Business Table 149. Towa Yakuhin Latest Developments Table 150. Wockhardt Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 151. Wockhardt Lovir Drug Intermediate Product Portfolios and Specifications Table 152. Wockhardt Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 153. Wockhardt Main Business Table 154. Wockhardt Latest Developments Table 155. Takata Pharmaceutical Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 156. Takata Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications Table 157. Takata Pharmaceutical Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 158. Takata Pharmaceutical Main Business Table 159. Takata Pharmaceutical Latest Developments Table 160. Aliud Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 161. Aliud Lovir Drug Intermediate Product Portfolios and Specifications Table 162. Aliud Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 163. Aliud Main Business Table 164. Aliud Latest Developments Table 165. Amneal Pharma Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 166. Amneal Pharma Lovir Drug Intermediate Product Portfolios and Specifications Table 167. Amneal Pharma Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 168. Amneal Pharma Main Business Table 169. Amneal Pharma Latest Developments Table 170. Apotex Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 171. Apotex Lovir Drug Intermediate Product Portfolios and Specifications Table 172. Apotex Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 173. Apotex Main Business Table 174. Apotex Latest Developments Table 175. Arrow Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 176. Arrow Lovir Drug Intermediate Product Portfolios and Specifications Table 177. Arrow Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 178. Arrow Main Business Table 179. Arrow Latest Developments Table 180. Laboratoires Servier Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 181. Laboratoires Servier Lovir Drug Intermediate Product Portfolios and Specifications Table 182. Laboratoires Servier Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 183. Laboratoires Servier Main Business Table 184. Laboratoires Servier Latest Developments Table 185. Sanofi Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 186. Sanofi Lovir Drug Intermediate Product Portfolios and Specifications Table 187. Sanofi Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 188. Sanofi Main Business Table 189. Sanofi Latest Developments Table 190. Mylan Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 191. Mylan Lovir Drug Intermediate Product Portfolios and Specifications Table 192. Mylan Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 193. Mylan Main Business Table 194. Mylan Latest Developments Table 195. Orion Pharma Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 196. Orion Pharma Lovir Drug Intermediate Product Portfolios and Specifications Table 197. Orion Pharma Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 198. Orion Pharma Main Business Table 199. Orion Pharma Latest Developments Table 200. Pfizer Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 201. Pfizer Lovir Drug Intermediate Product Portfolios and Specifications Table 202. Pfizer Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 203. Pfizer Main Business Table 204. Pfizer Latest Developments List of Figures Figure 1. Picture of Lovir Drug Intermediate Figure 2. Lovir Drug Intermediate Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Lovir Drug Intermediate Sales Growth Rate 2020-2031 (Tons) Figure 7. Global Lovir Drug Intermediate Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Lovir Drug Intermediate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Lovir Drug Intermediate Sales Market Share by Country/Region (2024) Figure 10. Lovir Drug Intermediate Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Acyclovir Figure 12. Product Picture of Zidovudine Figure 13. Product Picture of Entecavir Figure 14. Product Picture of Sofosbuvir Figure 15. Product Picture of Other Figure 16. Global Lovir Drug Intermediate Sales Market Share by Type in 2025 Figure 17. Global Lovir Drug Intermediate Revenue Market Share by Type (2020-2025) Figure 18. Lovir Drug Intermediate Consumed in Hospital Figure 19. Global Lovir Drug Intermediate Market: Hospital (2020-2025) & (Tons) Figure 20. Lovir Drug Intermediate Consumed in Clinic Figure 21. Global Lovir Drug Intermediate Market: Clinic (2020-2025) & (Tons) Figure 22. Lovir Drug Intermediate Consumed in Other Figure 23. Global Lovir Drug Intermediate Market: Other (2020-2025) & (Tons) Figure 24. Global Lovir Drug Intermediate Sale Market Share by Application (2024) Figure 25. Global Lovir Drug Intermediate Revenue Market Share by Application in 2025 Figure 26. Lovir Drug Intermediate Sales by Company in 2025 (Tons) Figure 27. Global Lovir Drug Intermediate Sales Market Share by Company in 2025 Figure 28. Lovir Drug Intermediate Revenue by Company in 2025 ($ millions) Figure 29. Global Lovir Drug Intermediate Revenue Market Share by Company in 2025 Figure 30. Global Lovir Drug Intermediate Sales Market Share by Geographic Region (2020-2025) Figure 31. Global Lovir Drug Intermediate Revenue Market Share by Geographic Region in 2025 Figure 32. Americas Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 33. Americas Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 34. APAC Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 35. APAC Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 36. Europe Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 37. Europe Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 38. Middle East & Africa Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 39. Middle East & Africa Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 40. Americas Lovir Drug Intermediate Sales Market Share by Country in 2025 Figure 41. Americas Lovir Drug Intermediate Revenue Market Share by Country (2020-2025) Figure 42. Americas Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 43. Americas Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 44. United States Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 45. Canada Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 46. Mexico Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 47. Brazil Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 48. APAC Lovir Drug Intermediate Sales Market Share by Region in 2025 Figure 49. APAC Lovir Drug Intermediate Revenue Market Share by Region (2020-2025) Figure 50. APAC Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 51. APAC Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 52. China Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 53. Japan Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 54. South Korea Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 55. Southeast Asia Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 56. India Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 57. Australia Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 58. China Taiwan Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 59. Europe Lovir Drug Intermediate Sales Market Share by Country in 2025 Figure 60. Europe Lovir Drug Intermediate Revenue Market Share by Country (2020-2025) Figure 61. Europe Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 62. Europe Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 63. Germany Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 64. France Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 65. UK Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 66. Italy Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 67. Russia Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 68. Middle East & Africa Lovir Drug Intermediate Sales Market Share by Country (2020-2025) Figure 69. Middle East & Africa Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 70. Middle East & Africa Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 71. Egypt Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 72. South Africa Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 73. Israel Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 74. Turkey Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 75. GCC Countries Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 76. Manufacturing Cost Structure Analysis of Lovir Drug Intermediate in 2025 Figure 77. Manufacturing Process Analysis of Lovir Drug Intermediate Figure 78. Industry Chain Structure of Lovir Drug Intermediate Figure 79. Channels of Distribution Figure 80. Global Lovir Drug Intermediate Sales Market Forecast by Region (2026-2031) Figure 81. Global Lovir Drug Intermediate Revenue Market Share Forecast by Region (2026-2031) Figure 82. Global Lovir Drug Intermediate Sales Market Share Forecast by Type (2026-2031) Figure 83. Global Lovir Drug Intermediate Revenue Market Share Forecast by Type (2026-2031) Figure 84. Global Lovir Drug Intermediate Sales Market Share Forecast by Application (2026-2031) Figure 85. Global Lovir Drug Intermediate Revenue Market Share Forecast by Application (2026-2031)
SummaryThe global Lovir Drug Intermediate market size is predicted to grow from US$ 777 million in 2025 to US$ 1127 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.A Lovir drug intermediate is a chemical precursor used in the synthesis of Lovir-class antiviral drugs, which are nucleoside analogs designed to inhibit viral replication. United States market for Lovir Drug Intermediate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Lovir Drug Intermediate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Lovir Drug Intermediate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Lovir Drug Intermediate players cover Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LP Information, Inc. (LPI) ' newest research report, the “Lovir Drug Intermediate Industry Forecast” looks at past sales and reviews total world Lovir Drug Intermediate sales in 2024, providing a comprehensive analysis by region and market sector of projected Lovir Drug Intermediate sales for 2025 through 2031. With Lovir Drug Intermediate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lovir Drug Intermediate industry. This Insight Report provides a comprehensive analysis of the global Lovir Drug Intermediate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lovir Drug Intermediate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lovir Drug Intermediate market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lovir Drug Intermediate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lovir Drug Intermediate. This report presents a comprehensive overview, market shares, and growth opportunities of Lovir Drug Intermediate market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Acyclovir Zidovudine Entecavir Sofosbuvir Other Segmentation by Application: Hospital Clinic Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Greater Pharma LBS Labs GlaxoSmithKline Lex Ano Salutas Novartis Teva Stada Nordic Cimed Industria de Medicamentos Reman Drug L.E.T.I. Nichi-Iko Pharmaceutical Choseido Pharmaceutical Shiono Kemikaru Towa Yakuhin Wockhardt Takata Pharmaceutical Aliud Amneal Pharma Apotex Arrow Laboratoires Servier Sanofi Mylan Orion Pharma Pfizer Key Questions Addressed in this Report What is the 10-year outlook for the global Lovir Drug Intermediate market? What factors are driving Lovir Drug Intermediate market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Lovir Drug Intermediate market opportunities vary by end market size? How does Lovir Drug Intermediate break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Lovir Drug Intermediate Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Lovir Drug Intermediate by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Lovir Drug Intermediate by Country/Region, 2020, 2024 & 2031 2.2 Lovir Drug Intermediate Segment by Type 2.2.1 Acyclovir 2.2.2 Zidovudine 2.2.3 Entecavir 2.2.4 Sofosbuvir 2.2.5 Other 2.3 Lovir Drug Intermediate Sales by Type 2.3.1 Global Lovir Drug Intermediate Sales Market Share by Type (2020-2025) 2.3.2 Global Lovir Drug Intermediate Revenue and Market Share by Type (2020-2025) 2.3.3 Global Lovir Drug Intermediate Sale Price by Type (2020-2025) 2.4 Lovir Drug Intermediate Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Other 2.5 Lovir Drug Intermediate Sales by Application 2.5.1 Global Lovir Drug Intermediate Sale Market Share by Application (2020-2025) 2.5.2 Global Lovir Drug Intermediate Revenue and Market Share by Application (2020-2025) 2.5.3 Global Lovir Drug Intermediate Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Lovir Drug Intermediate Breakdown Data by Company 3.1.1 Global Lovir Drug Intermediate Annual Sales by Company (2020-2025) 3.1.2 Global Lovir Drug Intermediate Sales Market Share by Company (2020-2025) 3.2 Global Lovir Drug Intermediate Annual Revenue by Company (2020-2025) 3.2.1 Global Lovir Drug Intermediate Revenue by Company (2020-2025) 3.2.2 Global Lovir Drug Intermediate Revenue Market Share by Company (2020-2025) 3.3 Global Lovir Drug Intermediate Sale Price by Company 3.4 Key Manufacturers Lovir Drug Intermediate Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Lovir Drug Intermediate Product Location Distribution 3.4.2 Players Lovir Drug Intermediate Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Lovir Drug Intermediate by Geographic Region 4.1 World Historic Lovir Drug Intermediate Market Size by Geographic Region (2020-2025) 4.1.1 Global Lovir Drug Intermediate Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Lovir Drug Intermediate Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Lovir Drug Intermediate Market Size by Country/Region (2020-2025) 4.2.1 Global Lovir Drug Intermediate Annual Sales by Country/Region (2020-2025) 4.2.2 Global Lovir Drug Intermediate Annual Revenue by Country/Region (2020-2025) 4.3 Americas Lovir Drug Intermediate Sales Growth 4.4 APAC Lovir Drug Intermediate Sales Growth 4.5 Europe Lovir Drug Intermediate Sales Growth 4.6 Middle East & Africa Lovir Drug Intermediate Sales Growth 5 Americas 5.1 Americas Lovir Drug Intermediate Sales by Country 5.1.1 Americas Lovir Drug Intermediate Sales by Country (2020-2025) 5.1.2 Americas Lovir Drug Intermediate Revenue by Country (2020-2025) 5.2 Americas Lovir Drug Intermediate Sales by Type (2020-2025) 5.3 Americas Lovir Drug Intermediate Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Lovir Drug Intermediate Sales by Region 6.1.1 APAC Lovir Drug Intermediate Sales by Region (2020-2025) 6.1.2 APAC Lovir Drug Intermediate Revenue by Region (2020-2025) 6.2 APAC Lovir Drug Intermediate Sales by Type (2020-2025) 6.3 APAC Lovir Drug Intermediate Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Lovir Drug Intermediate by Country 7.1.1 Europe Lovir Drug Intermediate Sales by Country (2020-2025) 7.1.2 Europe Lovir Drug Intermediate Revenue by Country (2020-2025) 7.2 Europe Lovir Drug Intermediate Sales by Type (2020-2025) 7.3 Europe Lovir Drug Intermediate Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Lovir Drug Intermediate by Country 8.1.1 Middle East & Africa Lovir Drug Intermediate Sales by Country (2020-2025) 8.1.2 Middle East & Africa Lovir Drug Intermediate Revenue by Country (2020-2025) 8.2 Middle East & Africa Lovir Drug Intermediate Sales by Type (2020-2025) 8.3 Middle East & Africa Lovir Drug Intermediate Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Lovir Drug Intermediate 10.3 Manufacturing Process Analysis of Lovir Drug Intermediate 10.4 Industry Chain Structure of Lovir Drug Intermediate 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Lovir Drug Intermediate Distributors 11.3 Lovir Drug Intermediate Customer 12 World Forecast Review for Lovir Drug Intermediate by Geographic Region 12.1 Global Lovir Drug Intermediate Market Size Forecast by Region 12.1.1 Global Lovir Drug Intermediate Forecast by Region (2026-2031) 12.1.2 Global Lovir Drug Intermediate Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Lovir Drug Intermediate Forecast by Type (2026-2031) 12.7 Global Lovir Drug Intermediate Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Greater Pharma 13.1.1 Greater Pharma Company Information 13.1.2 Greater Pharma Lovir Drug Intermediate Product Portfolios and Specifications 13.1.3 Greater Pharma Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Greater Pharma Main Business Overview 13.1.5 Greater Pharma Latest Developments 13.2 LBS Labs 13.2.1 LBS Labs Company Information 13.2.2 LBS Labs Lovir Drug Intermediate Product Portfolios and Specifications 13.2.3 LBS Labs Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 LBS Labs Main Business Overview 13.2.5 LBS Labs Latest Developments 13.3 GlaxoSmithKline 13.3.1 GlaxoSmithKline Company Information 13.3.2 GlaxoSmithKline Lovir Drug Intermediate Product Portfolios and Specifications 13.3.3 GlaxoSmithKline Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 GlaxoSmithKline Main Business Overview 13.3.5 GlaxoSmithKline Latest Developments 13.4 Lex Ano 13.4.1 Lex Ano Company Information 13.4.2 Lex Ano Lovir Drug Intermediate Product Portfolios and Specifications 13.4.3 Lex Ano Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Lex Ano Main Business Overview 13.4.5 Lex Ano Latest Developments 13.5 Salutas 13.5.1 Salutas Company Information 13.5.2 Salutas Lovir Drug Intermediate Product Portfolios and Specifications 13.5.3 Salutas Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 Salutas Main Business Overview 13.5.5 Salutas Latest Developments 13.6 Novartis 13.6.1 Novartis Company Information 13.6.2 Novartis Lovir Drug Intermediate Product Portfolios and Specifications 13.6.3 Novartis Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Novartis Main Business Overview 13.6.5 Novartis Latest Developments 13.7 Teva 13.7.1 Teva Company Information 13.7.2 Teva Lovir Drug Intermediate Product Portfolios and Specifications 13.7.3 Teva Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Teva Main Business Overview 13.7.5 Teva Latest Developments 13.8 Stada Nordic 13.8.1 Stada Nordic Company Information 13.8.2 Stada Nordic Lovir Drug Intermediate Product Portfolios and Specifications 13.8.3 Stada Nordic Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Stada Nordic Main Business Overview 13.8.5 Stada Nordic Latest Developments 13.9 Cimed Industria de Medicamentos 13.9.1 Cimed Industria de Medicamentos Company Information 13.9.2 Cimed Industria de Medicamentos Lovir Drug Intermediate Product Portfolios and Specifications 13.9.3 Cimed Industria de Medicamentos Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Cimed Industria de Medicamentos Main Business Overview 13.9.5 Cimed Industria de Medicamentos Latest Developments 13.10 Reman Drug 13.10.1 Reman Drug Company Information 13.10.2 Reman Drug Lovir Drug Intermediate Product Portfolios and Specifications 13.10.3 Reman Drug Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Reman Drug Main Business Overview 13.10.5 Reman Drug Latest Developments 13.11 L.E.T.I. 13.11.1 L.E.T.I. Company Information 13.11.2 L.E.T.I. Lovir Drug Intermediate Product Portfolios and Specifications 13.11.3 L.E.T.I. Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.11.4 L.E.T.I. Main Business Overview 13.11.5 L.E.T.I. Latest Developments 13.12 Nichi-Iko Pharmaceutical 13.12.1 Nichi-Iko Pharmaceutical Company Information 13.12.2 Nichi-Iko Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications 13.12.3 Nichi-Iko Pharmaceutical Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.12.4 Nichi-Iko Pharmaceutical Main Business Overview 13.12.5 Nichi-Iko Pharmaceutical Latest Developments 13.13 Choseido Pharmaceutical 13.13.1 Choseido Pharmaceutical Company Information 13.13.2 Choseido Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications 13.13.3 Choseido Pharmaceutical Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.13.4 Choseido Pharmaceutical Main Business Overview 13.13.5 Choseido Pharmaceutical Latest Developments 13.14 Shiono Kemikaru 13.14.1 Shiono Kemikaru Company Information 13.14.2 Shiono Kemikaru Lovir Drug Intermediate Product Portfolios and Specifications 13.14.3 Shiono Kemikaru Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.14.4 Shiono Kemikaru Main Business Overview 13.14.5 Shiono Kemikaru Latest Developments 13.15 Towa Yakuhin 13.15.1 Towa Yakuhin Company Information 13.15.2 Towa Yakuhin Lovir Drug Intermediate Product Portfolios and Specifications 13.15.3 Towa Yakuhin Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.15.4 Towa Yakuhin Main Business Overview 13.15.5 Towa Yakuhin Latest Developments 13.16 Wockhardt 13.16.1 Wockhardt Company Information 13.16.2 Wockhardt Lovir Drug Intermediate Product Portfolios and Specifications 13.16.3 Wockhardt Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.16.4 Wockhardt Main Business Overview 13.16.5 Wockhardt Latest Developments 13.17 Takata Pharmaceutical 13.17.1 Takata Pharmaceutical Company Information 13.17.2 Takata Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications 13.17.3 Takata Pharmaceutical Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.17.4 Takata Pharmaceutical Main Business Overview 13.17.5 Takata Pharmaceutical Latest Developments 13.18 Aliud 13.18.1 Aliud Company Information 13.18.2 Aliud Lovir Drug Intermediate Product Portfolios and Specifications 13.18.3 Aliud Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.18.4 Aliud Main Business Overview 13.18.5 Aliud Latest Developments 13.19 Amneal Pharma 13.19.1 Amneal Pharma Company Information 13.19.2 Amneal Pharma Lovir Drug Intermediate Product Portfolios and Specifications 13.19.3 Amneal Pharma Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.19.4 Amneal Pharma Main Business Overview 13.19.5 Amneal Pharma Latest Developments 13.20 Apotex 13.20.1 Apotex Company Information 13.20.2 Apotex Lovir Drug Intermediate Product Portfolios and Specifications 13.20.3 Apotex Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.20.4 Apotex Main Business Overview 13.20.5 Apotex Latest Developments 13.21 Arrow 13.21.1 Arrow Company Information 13.21.2 Arrow Lovir Drug Intermediate Product Portfolios and Specifications 13.21.3 Arrow Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.21.4 Arrow Main Business Overview 13.21.5 Arrow Latest Developments 13.22 Laboratoires Servier 13.22.1 Laboratoires Servier Company Information 13.22.2 Laboratoires Servier Lovir Drug Intermediate Product Portfolios and Specifications 13.22.3 Laboratoires Servier Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.22.4 Laboratoires Servier Main Business Overview 13.22.5 Laboratoires Servier Latest Developments 13.23 Sanofi 13.23.1 Sanofi Company Information 13.23.2 Sanofi Lovir Drug Intermediate Product Portfolios and Specifications 13.23.3 Sanofi Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.23.4 Sanofi Main Business Overview 13.23.5 Sanofi Latest Developments 13.24 Mylan 13.24.1 Mylan Company Information 13.24.2 Mylan Lovir Drug Intermediate Product Portfolios and Specifications 13.24.3 Mylan Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.24.4 Mylan Main Business Overview 13.24.5 Mylan Latest Developments 13.25 Orion Pharma 13.25.1 Orion Pharma Company Information 13.25.2 Orion Pharma Lovir Drug Intermediate Product Portfolios and Specifications 13.25.3 Orion Pharma Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.25.4 Orion Pharma Main Business Overview 13.25.5 Orion Pharma Latest Developments 13.26 Pfizer 13.26.1 Pfizer Company Information 13.26.2 Pfizer Lovir Drug Intermediate Product Portfolios and Specifications 13.26.3 Pfizer Lovir Drug Intermediate Sales, Revenue, Price and Gross Margin (2020-2025) 13.26.4 Pfizer Main Business Overview 13.26.5 Pfizer Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Lovir Drug Intermediate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Lovir Drug Intermediate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Acyclovir Table 4. Major Players of Zidovudine Table 5. Major Players of Entecavir Table 6. Major Players of Sofosbuvir Table 7. Major Players of Other Table 8. Global Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 9. Global Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Table 10. Global Lovir Drug Intermediate Revenue by Type (2020-2025) & ($ million) Table 11. Global Lovir Drug Intermediate Revenue Market Share by Type (2020-2025) Table 12. Global Lovir Drug Intermediate Sale Price by Type (2020-2025) & (US$/Ton) Table 13. Global Lovir Drug Intermediate Sale by Application (2020-2025) & (Tons) Table 14. Global Lovir Drug Intermediate Sale Market Share by Application (2020-2025) Table 15. Global Lovir Drug Intermediate Revenue by Application (2020-2025) & ($ million) Table 16. Global Lovir Drug Intermediate Revenue Market Share by Application (2020-2025) Table 17. Global Lovir Drug Intermediate Sale Price by Application (2020-2025) & (US$/Ton) Table 18. Global Lovir Drug Intermediate Sales by Company (2020-2025) & (Tons) Table 19. Global Lovir Drug Intermediate Sales Market Share by Company (2020-2025) Table 20. Global Lovir Drug Intermediate Revenue by Company (2020-2025) & ($ millions) Table 21. Global Lovir Drug Intermediate Revenue Market Share by Company (2020-2025) Table 22. Global Lovir Drug Intermediate Sale Price by Company (2020-2025) & (US$/Ton) Table 23. Key Manufacturers Lovir Drug Intermediate Producing Area Distribution and Sales Area Table 24. Players Lovir Drug Intermediate Products Offered Table 25. Lovir Drug Intermediate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 26. New Products and Potential Entrants Table 27. Market M&A Activity & Strategy Table 28. Global Lovir Drug Intermediate Sales by Geographic Region (2020-2025) & (Tons) Table 29. Global Lovir Drug Intermediate Sales Market Share Geographic Region (2020-2025) Table 30. Global Lovir Drug Intermediate Revenue by Geographic Region (2020-2025) & ($ millions) Table 31. Global Lovir Drug Intermediate Revenue Market Share by Geographic Region (2020-2025) Table 32. Global Lovir Drug Intermediate Sales by Country/Region (2020-2025) & (Tons) Table 33. Global Lovir Drug Intermediate Sales Market Share by Country/Region (2020-2025) Table 34. Global Lovir Drug Intermediate Revenue by Country/Region (2020-2025) & ($ millions) Table 35. Global Lovir Drug Intermediate Revenue Market Share by Country/Region (2020-2025) Table 36. Americas Lovir Drug Intermediate Sales by Country (2020-2025) & (Tons) Table 37. Americas Lovir Drug Intermediate Sales Market Share by Country (2020-2025) Table 38. Americas Lovir Drug Intermediate Revenue by Country (2020-2025) & ($ millions) Table 39. Americas Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 40. Americas Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 41. APAC Lovir Drug Intermediate Sales by Region (2020-2025) & (Tons) Table 42. APAC Lovir Drug Intermediate Sales Market Share by Region (2020-2025) Table 43. APAC Lovir Drug Intermediate Revenue by Region (2020-2025) & ($ millions) Table 44. APAC Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 45. APAC Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 46. Europe Lovir Drug Intermediate Sales by Country (2020-2025) & (Tons) Table 47. Europe Lovir Drug Intermediate Revenue by Country (2020-2025) & ($ millions) Table 48. Europe Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 49. Europe Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 50. Middle East & Africa Lovir Drug Intermediate Sales by Country (2020-2025) & (Tons) Table 51. Middle East & Africa Lovir Drug Intermediate Revenue Market Share by Country (2020-2025) Table 52. Middle East & Africa Lovir Drug Intermediate Sales by Type (2020-2025) & (Tons) Table 53. Middle East & Africa Lovir Drug Intermediate Sales by Application (2020-2025) & (Tons) Table 54. Key Market Drivers & Growth Opportunities of Lovir Drug Intermediate Table 55. Key Market Challenges & Risks of Lovir Drug Intermediate Table 56. Key Industry Trends of Lovir Drug Intermediate Table 57. Lovir Drug Intermediate Raw Material Table 58. Key Suppliers of Raw Materials Table 59. Lovir Drug Intermediate Distributors List Table 60. Lovir Drug Intermediate Customer List Table 61. Global Lovir Drug Intermediate Sales Forecast by Region (2026-2031) & (Tons) Table 62. Global Lovir Drug Intermediate Revenue Forecast by Region (2026-2031) & ($ millions) Table 63. Americas Lovir Drug Intermediate Sales Forecast by Country (2026-2031) & (Tons) Table 64. Americas Lovir Drug Intermediate Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 65. APAC Lovir Drug Intermediate Sales Forecast by Region (2026-2031) & (Tons) Table 66. APAC Lovir Drug Intermediate Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 67. Europe Lovir Drug Intermediate Sales Forecast by Country (2026-2031) & (Tons) Table 68. Europe Lovir Drug Intermediate Revenue Forecast by Country (2026-2031) & ($ millions) Table 69. Middle East & Africa Lovir Drug Intermediate Sales Forecast by Country (2026-2031) & (Tons) Table 70. Middle East & Africa Lovir Drug Intermediate Revenue Forecast by Country (2026-2031) & ($ millions) Table 71. Global Lovir Drug Intermediate Sales Forecast by Type (2026-2031) & (Tons) Table 72. Global Lovir Drug Intermediate Revenue Forecast by Type (2026-2031) & ($ millions) Table 73. Global Lovir Drug Intermediate Sales Forecast by Application (2026-2031) & (Tons) Table 74. Global Lovir Drug Intermediate Revenue Forecast by Application (2026-2031) & ($ millions) Table 75. Greater Pharma Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 76. Greater Pharma Lovir Drug Intermediate Product Portfolios and Specifications Table 77. Greater Pharma Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 78. Greater Pharma Main Business Table 79. Greater Pharma Latest Developments Table 80. LBS Labs Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 81. LBS Labs Lovir Drug Intermediate Product Portfolios and Specifications Table 82. LBS Labs Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 83. LBS Labs Main Business Table 84. LBS Labs Latest Developments Table 85. GlaxoSmithKline Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 86. GlaxoSmithKline Lovir Drug Intermediate Product Portfolios and Specifications Table 87. GlaxoSmithKline Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 88. GlaxoSmithKline Main Business Table 89. GlaxoSmithKline Latest Developments Table 90. Lex Ano Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 91. Lex Ano Lovir Drug Intermediate Product Portfolios and Specifications Table 92. Lex Ano Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 93. Lex Ano Main Business Table 94. Lex Ano Latest Developments Table 95. Salutas Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 96. Salutas Lovir Drug Intermediate Product Portfolios and Specifications Table 97. Salutas Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 98. Salutas Main Business Table 99. Salutas Latest Developments Table 100. Novartis Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 101. Novartis Lovir Drug Intermediate Product Portfolios and Specifications Table 102. Novartis Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 103. Novartis Main Business Table 104. Novartis Latest Developments Table 105. Teva Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 106. Teva Lovir Drug Intermediate Product Portfolios and Specifications Table 107. Teva Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 108. Teva Main Business Table 109. Teva Latest Developments Table 110. Stada Nordic Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 111. Stada Nordic Lovir Drug Intermediate Product Portfolios and Specifications Table 112. Stada Nordic Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 113. Stada Nordic Main Business Table 114. Stada Nordic Latest Developments Table 115. Cimed Industria de Medicamentos Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 116. Cimed Industria de Medicamentos Lovir Drug Intermediate Product Portfolios and Specifications Table 117. Cimed Industria de Medicamentos Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 118. Cimed Industria de Medicamentos Main Business Table 119. Cimed Industria de Medicamentos Latest Developments Table 120. Reman Drug Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 121. Reman Drug Lovir Drug Intermediate Product Portfolios and Specifications Table 122. Reman Drug Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 123. Reman Drug Main Business Table 124. Reman Drug Latest Developments Table 125. L.E.T.I. Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 126. L.E.T.I. Lovir Drug Intermediate Product Portfolios and Specifications Table 127. L.E.T.I. Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 128. L.E.T.I. Main Business Table 129. L.E.T.I. Latest Developments Table 130. Nichi-Iko Pharmaceutical Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 131. Nichi-Iko Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications Table 132. Nichi-Iko Pharmaceutical Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 133. Nichi-Iko Pharmaceutical Main Business Table 134. Nichi-Iko Pharmaceutical Latest Developments Table 135. Choseido Pharmaceutical Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 136. Choseido Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications Table 137. Choseido Pharmaceutical Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 138. Choseido Pharmaceutical Main Business Table 139. Choseido Pharmaceutical Latest Developments Table 140. Shiono Kemikaru Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 141. Shiono Kemikaru Lovir Drug Intermediate Product Portfolios and Specifications Table 142. Shiono Kemikaru Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 143. Shiono Kemikaru Main Business Table 144. Shiono Kemikaru Latest Developments Table 145. Towa Yakuhin Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 146. Towa Yakuhin Lovir Drug Intermediate Product Portfolios and Specifications Table 147. Towa Yakuhin Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 148. Towa Yakuhin Main Business Table 149. Towa Yakuhin Latest Developments Table 150. Wockhardt Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 151. Wockhardt Lovir Drug Intermediate Product Portfolios and Specifications Table 152. Wockhardt Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 153. Wockhardt Main Business Table 154. Wockhardt Latest Developments Table 155. Takata Pharmaceutical Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 156. Takata Pharmaceutical Lovir Drug Intermediate Product Portfolios and Specifications Table 157. Takata Pharmaceutical Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 158. Takata Pharmaceutical Main Business Table 159. Takata Pharmaceutical Latest Developments Table 160. Aliud Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 161. Aliud Lovir Drug Intermediate Product Portfolios and Specifications Table 162. Aliud Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 163. Aliud Main Business Table 164. Aliud Latest Developments Table 165. Amneal Pharma Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 166. Amneal Pharma Lovir Drug Intermediate Product Portfolios and Specifications Table 167. Amneal Pharma Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 168. Amneal Pharma Main Business Table 169. Amneal Pharma Latest Developments Table 170. Apotex Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 171. Apotex Lovir Drug Intermediate Product Portfolios and Specifications Table 172. Apotex Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 173. Apotex Main Business Table 174. Apotex Latest Developments Table 175. Arrow Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 176. Arrow Lovir Drug Intermediate Product Portfolios and Specifications Table 177. Arrow Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 178. Arrow Main Business Table 179. Arrow Latest Developments Table 180. Laboratoires Servier Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 181. Laboratoires Servier Lovir Drug Intermediate Product Portfolios and Specifications Table 182. Laboratoires Servier Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 183. Laboratoires Servier Main Business Table 184. Laboratoires Servier Latest Developments Table 185. Sanofi Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 186. Sanofi Lovir Drug Intermediate Product Portfolios and Specifications Table 187. Sanofi Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 188. Sanofi Main Business Table 189. Sanofi Latest Developments Table 190. Mylan Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 191. Mylan Lovir Drug Intermediate Product Portfolios and Specifications Table 192. Mylan Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 193. Mylan Main Business Table 194. Mylan Latest Developments Table 195. Orion Pharma Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 196. Orion Pharma Lovir Drug Intermediate Product Portfolios and Specifications Table 197. Orion Pharma Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 198. Orion Pharma Main Business Table 199. Orion Pharma Latest Developments Table 200. Pfizer Basic Information, Lovir Drug Intermediate Manufacturing Base, Sales Area and Its Competitors Table 201. Pfizer Lovir Drug Intermediate Product Portfolios and Specifications Table 202. Pfizer Lovir Drug Intermediate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025) Table 203. Pfizer Main Business Table 204. Pfizer Latest Developments List of Figures Figure 1. Picture of Lovir Drug Intermediate Figure 2. Lovir Drug Intermediate Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Lovir Drug Intermediate Sales Growth Rate 2020-2031 (Tons) Figure 7. Global Lovir Drug Intermediate Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Lovir Drug Intermediate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Lovir Drug Intermediate Sales Market Share by Country/Region (2024) Figure 10. Lovir Drug Intermediate Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Acyclovir Figure 12. Product Picture of Zidovudine Figure 13. Product Picture of Entecavir Figure 14. Product Picture of Sofosbuvir Figure 15. Product Picture of Other Figure 16. Global Lovir Drug Intermediate Sales Market Share by Type in 2025 Figure 17. Global Lovir Drug Intermediate Revenue Market Share by Type (2020-2025) Figure 18. Lovir Drug Intermediate Consumed in Hospital Figure 19. Global Lovir Drug Intermediate Market: Hospital (2020-2025) & (Tons) Figure 20. Lovir Drug Intermediate Consumed in Clinic Figure 21. Global Lovir Drug Intermediate Market: Clinic (2020-2025) & (Tons) Figure 22. Lovir Drug Intermediate Consumed in Other Figure 23. Global Lovir Drug Intermediate Market: Other (2020-2025) & (Tons) Figure 24. Global Lovir Drug Intermediate Sale Market Share by Application (2024) Figure 25. Global Lovir Drug Intermediate Revenue Market Share by Application in 2025 Figure 26. Lovir Drug Intermediate Sales by Company in 2025 (Tons) Figure 27. Global Lovir Drug Intermediate Sales Market Share by Company in 2025 Figure 28. Lovir Drug Intermediate Revenue by Company in 2025 ($ millions) Figure 29. Global Lovir Drug Intermediate Revenue Market Share by Company in 2025 Figure 30. Global Lovir Drug Intermediate Sales Market Share by Geographic Region (2020-2025) Figure 31. Global Lovir Drug Intermediate Revenue Market Share by Geographic Region in 2025 Figure 32. Americas Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 33. Americas Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 34. APAC Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 35. APAC Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 36. Europe Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 37. Europe Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 38. Middle East & Africa Lovir Drug Intermediate Sales 2020-2025 (Tons) Figure 39. Middle East & Africa Lovir Drug Intermediate Revenue 2020-2025 ($ millions) Figure 40. Americas Lovir Drug Intermediate Sales Market Share by Country in 2025 Figure 41. Americas Lovir Drug Intermediate Revenue Market Share by Country (2020-2025) Figure 42. Americas Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 43. Americas Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 44. United States Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 45. Canada Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 46. Mexico Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 47. Brazil Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 48. APAC Lovir Drug Intermediate Sales Market Share by Region in 2025 Figure 49. APAC Lovir Drug Intermediate Revenue Market Share by Region (2020-2025) Figure 50. APAC Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 51. APAC Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 52. China Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 53. Japan Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 54. South Korea Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 55. Southeast Asia Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 56. India Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 57. Australia Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 58. China Taiwan Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 59. Europe Lovir Drug Intermediate Sales Market Share by Country in 2025 Figure 60. Europe Lovir Drug Intermediate Revenue Market Share by Country (2020-2025) Figure 61. Europe Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 62. Europe Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 63. Germany Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 64. France Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 65. UK Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 66. Italy Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 67. Russia Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 68. Middle East & Africa Lovir Drug Intermediate Sales Market Share by Country (2020-2025) Figure 69. Middle East & Africa Lovir Drug Intermediate Sales Market Share by Type (2020-2025) Figure 70. Middle East & Africa Lovir Drug Intermediate Sales Market Share by Application (2020-2025) Figure 71. Egypt Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 72. South Africa Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 73. Israel Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 74. Turkey Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 75. GCC Countries Lovir Drug Intermediate Revenue Growth 2020-2025 ($ millions) Figure 76. Manufacturing Cost Structure Analysis of Lovir Drug Intermediate in 2025 Figure 77. Manufacturing Process Analysis of Lovir Drug Intermediate Figure 78. Industry Chain Structure of Lovir Drug Intermediate Figure 79. Channels of Distribution Figure 80. Global Lovir Drug Intermediate Sales Market Forecast by Region (2026-2031) Figure 81. Global Lovir Drug Intermediate Revenue Market Share Forecast by Region (2026-2031) Figure 82. Global Lovir Drug Intermediate Sales Market Share Forecast by Type (2026-2031) Figure 83. Global Lovir Drug Intermediate Revenue Market Share Forecast by Type (2026-2031) Figure 84. Global Lovir Drug Intermediate Sales Market Share Forecast by Application (2026-2031) Figure 85. Global Lovir Drug Intermediate Revenue Market Share Forecast by Application (2026-2031)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
